https://www.selleckchem.com/pr....oducts/iacs-13909.ht
Intracerebral haemorrhage (ICH) can be devastating and is a common cause of death and disability worldwide. Pre-ICH antiplatelet drug use is associated with a 27% relative increase in 1 month case fatality compared with patients not using antithrombotic drugs. We aim to assess the feasibility of conducting a randomised controlled testing the safety and efficacy of desmopressin for patients with antiplatelet-associated ICH. We aim to include 50 patients within 24 hours of spontaneous ICH onset, associated with oral antiplatelet drug(s
Like
Comment
Share
